Short-term risk of cardiovascular events in people newly diagnosed with gout.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
15 Sep 2024
Historique:
revised: 25 07 2024
received: 09 04 2024
accepted: 10 09 2024
medline: 16 9 2024
pubmed: 16 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

To investigate the temporal association between first diagnosis of gout and cardiovascular events in the short-term. We performed a self-controlled case series analysis and a cohort study using data from linked primary care, hospitalisation, and mortality records from the UK's Clinical Practice Research Database (GOLD). We included individuals with a new diagnosis of gout either in the primary care or secondary care between 01/01/1997 and 31/12/2020. The first consultation at which gout was diagnosed was the exposure of interest. The main outcome consisted of cardiovascular events (i.e., a composite of fatal and non-fatal myocardial infarction, ischaemic or haemorrhagic stroke, and transient ischaemic attack). 4,398 patients (66.9% male, mean age 74.6 years) had a cardiovascular event within ±2 years of their first recorded diagnosis of gout. The incidence of cardiovascular events was significantly higher in the 30 days after the first diagnosis of gout compared to baseline (adjusted incidence rate ratio: 1.55 ((95% confidence interval) 95%CI: 1.33-1.83)). Among 76,440 patients (72.9% male, mean age 63.2 years) included in the cohort study, the incidence of cardiovascular events in the 30 days after the first gout diagnosis (31.2 events/1,000 person-years, 95%CI: 27.1-35.9) was significantly higher than in days 31-730 after gout diagnosis (21.6 events/1,000 person-years, 95%CI:20.8-22.4) with a rate difference of -9.6 events/1,000 person-years, 95%CI: -14.0 to -5.1). Individuals had a short-term increased risk of cardiovascular events in the 30 days following the first consultation at which gout was diagnosed.

Identifiants

pubmed: 39279144
doi: 10.1002/art.42986
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

Edoardo Cipolletta (E)

Academic Rheumatology, University of Nottingham, Nottingham, NG5 1PB, UK.
Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, 60126, Italy.

Georgina Nakafero (G)

Academic Rheumatology, University of Nottingham, Nottingham, NG5 1PB, UK.

Pascal Richette (P)

Rheumatology Department, Hospital Lariboisière, Paris, INSERM U1132, France.

Anthony J Avery (AJ)

Centre for Academic Primary Care, School of Medicine, University of Nottingham, Nottingham, NG7 2RD, UK.

Mamas A Mamas (MA)

Keele Cardiovascular Research Group, Keele University, Keele, ST5 5BG, UK.

Laila J Tata (LJ)

Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, NG5 1PB, UK.

Abhishek Abhishek (A)

Academic Rheumatology, University of Nottingham, Nottingham, NG5 1PB, UK.

Classifications MeSH